List of Tables
List of Figures
Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Premenstrual Syndrome to Women's Health Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Premenstrual Syndrome to Women's Health Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Premenstrual Syndrome Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Source

List of Tables
Premenstrual Syndrome Therapeutics, Global, Clinical Trials by Region, 2020*
Premenstrual Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
Premenstrual Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
Premenstrual Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
Premenstrual Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
Premenstrual Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2020*
Premenstrual Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2020*
Premenstrual Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2020*
Proportion of Premenstrual Syndrome to Women's Health Clinical Trials, G7 Countries (%), 2020*
Premenstrual Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
Premenstrual Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
Proportion of Premenstrual Syndrome to Women's Health Clinical Trials, E7 Countries (%), 2020*
Premenstrual Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
Premenstrual Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
Premenstrual Syndrome Therapeutics, Global, Clinical Trials by Phase, 2020*
Premenstrual Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
Premenstrual Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2020*
Premenstrual Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2020*
Premenstrual Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
Premenstrual Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
Premenstrual Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
Premenstrual Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
Premenstrual Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

List of Figures
Premenstrual Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2020*
Premenstrual Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
Premenstrual Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
Premenstrual Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
Premenstrual Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
Premenstrual Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
Premenstrual Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2020*
Premenstrual Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2020*
Proportion of Premenstrual Syndrome to Women's Health Clinical Trials, G7 Countries (%), 2020*
Premenstrual Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
Premenstrual Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
Proportion of Premenstrual Syndrome to Women's Health Clinical Trials, E7 Countries (%), 2020*
Premenstrual Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
Premenstrual Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
Premenstrual Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2020*
Premenstrual Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
Premenstrual Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2020*
Premenstrual Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2020*
Premenstrual Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
Premenstrual Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
Premenstrual Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
Premenstrual Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
Premenstrual Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
GlobalData Methodology

Companies Mentioned
- Pfizer Inc
- Torrent Pharmaceuticals Ltd
- Bayer AG
- Besins Healthcare SA
- Syneos Health Inc
- Umecrine AB
- AbbVie Inc
- Actavis Group PTC ehf
- Barij Essence Pharmaceutical Company
- Biokanol Pharma GmbH